Video

Digital Economy: The digitisation of healthcare w/ Jackie Hunter

What unique challenges surround the application of digital technologies in healthcare and how do we overcome them?

In this latest Digital Economy podcast from The Economist, Intelligence Unit host Pete Swabey discusses these challenges with Prof. Jackie Hunter, CE Clinical and Strategic Partnerships at BenevolentAI, Professor Ann Blandford, deputy director for digital health at the UCL Institute of Healthcare Engineering and Elizabeth Sukkar, Managing Editor and Global Editorial lead for healthcare at The EIU.

There are arguably few applications of digital technology more worthwhile than human health, however integrating technologies into healthcare systems is uniquely complex. This podcast provides an introduction to some of the challenges that healthcare providers face in their pursuit of digital innovation, and explores some of the paths forward. This episode touches upon issues ranging from health literacy, to the sensitivity of health data and the need for trust and transparency.

More Posts

You Might Also Like

Blog
Intern at BenevolentAI part I: meet our 2020 intern cohort
What impactful work did our interns get up to across Engineering, Data Science, ML and business operations this summer? Get to know them and their work in our tech internships blog.
Nov 26, 2020
News
FDA grants Emergency Use Authorisation for baricitinib in hospitalised COVID-19 patients nine months after initial hypothesis was published by BenevolentAI
BenevolentAI scientists first identified baricitinib as a potential treatment for COVID-19 in early February 2020 using Benevolent's AI tools and biomedical knowledge graph.
Nov 20, 2020
News
NeurIPS 2020: Meet the BenevolentAI team
BenevolentAI is happy to announce it is sponsoring NeurIPS 2020. Join us to hear about data diversity and ML applied drug discovery, and to learn about careers in the field.
Nov 17, 2020
Blog
Careers with Impact: 5 learnings from machine learning applied drug discovery
Last week, we brought together four of our exceptional colleagues for a panel discussion on careers in machine learning applied drug discovery. Here are some of our main takeaways:
Nov 17, 2020
Blog
Data published in Science Advances shows baricitinib reduces COVID-19 morbidity and mortality
Research published in Science Advances supports BenevolentAI’s AI-generated hypothesis from late January for baricitinib as a treatment for COVID-19.
Nov 13, 2020
News
Sir Nigel Shadbolt joins BenevolentAI as a non-executive director
BenevolentAI strengthens its Board with the appointment of AI pioneer Sir Nigel Shadbolt as Non-Executive Director.
Nov 3, 2020